Heart Disease Journals

Cardiology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Lee JM et al. - CYP2C19*3 single-nucleotide polymorphisms is an independent risk factor of clopidogrel resistance in Korean subjects with coronary artery disease.

Related Articles

Pharmacogenetic Testing for Clopidogrel Using the Rapid INFINITI Analyzer
JACC - Journal of the American College of Cardiology: Cardiovascular Interventions, 11/20/09    Relevance Score: 88%

Variable platelet responsiveness to aspirin and clopidogrel: role of platelet function and genetic polymorphism testing
Translational Research, The Journal of Laboratory and Clinical Medicine, 11/20/09    Relevance Score: 87%

Gender and Responses to Aspirin and Clopidogrel: Insights Using Short Thrombelastography
Cardiovascular Drug Reviews, 11/17/09    Relevance Score: 87%

Effectiveness of Two-Year Clopidogrel + Aspirin in Abolishing the Risk of Very Late Thrombosis After Drug-Eluting Stent Implantation (from the TYCOON [Two-Year ClOpidOgrel Need] Study)
The American Journal of Cardiology, 11/05/09    Relevance Score: 87%

Dual antiplatelet therapy in coronary artery disease: A case-based approach
Cleveland Clinic Journal of Medicine, 11/04/09    Relevance Score: 87%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address